# FDA Inspection 1224841 - Noraxon USA, Inc. - November 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/noraxon-usa-inc/192698b0-d8a1-4da8-bf1d-5fc481a3ed9e
Source feed: FDA_Inspections

> FDA Inspection 1224841 for Noraxon USA, Inc. on November 30, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224841
- Company Name: Noraxon USA, Inc.
- Inspection Date: 2023-11-30
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1224841 - 2023-11-30](https://www.keypedia.com/records/fda_inspections/noraxon-usa-inc/6962d3d8-06f0-4a5d-8ba6-875636f2be2c)
- [FDA Inspection 1065807 - 2018-09-11](https://www.keypedia.com/records/fda_inspections/noraxon-usa-inc/2a14ba9f-15b1-4c58-bebc-f4fe61a982b2)
- [FDA Inspection 1065807 - 2018-09-11](https://www.keypedia.com/records/fda_inspections/noraxon-usa-inc/5835c144-cd22-4d1c-bcd5-f2068c7e974b)
- [FDA Inspection 884760 - 2014-06-24](https://www.keypedia.com/records/fda_inspections/noraxon-usa-inc/e9132d42-2a74-45f4-964e-32bbce32dfaa)
- [FDA Inspection 884760 - 2014-06-24](https://www.keypedia.com/records/fda_inspections/noraxon-usa-inc/7b081596-3238-48d8-afec-5201640b2c40)

Company: https://www.keypedia.com/companies/noraxon-usa-inc/a3c2a806-a940-4a37-920d-b9e31915e7ba

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7